Abstract Natural products often do not possess the optimal properties for their use in human or animal medicine. The recent history of natural products would indicate that such optimization is likely. 2-Aryl-carbapenems were synthesized in an effort to improve upon the DHP-I susceptibility of the parent antibiotics. The synthesis of this class of compounds is described and they are indeed more DHP-I stable. However, it has not been possible to obtain meaningful anti-pseudomonal activity in this series.
Nature produces many natural products that are antibiotics, pharmacological agents or are otherwise of interest in human or animal medicine. While their purpose in nature remains obscure in most instances, clearly they are not intended by the producing microorganism or plant source to be of utility for the treatment of disease states. Accordingly, it seems likely that the properties of natural products can be optimized for their projected use. The recent history of natural products has indicated that this is indeed the case.
Imipenem 1 (N-formimidoylthienamycin, MK-0787) (ref. 1) is an excellent example of this approach. The natural product, thienamycin 2, while possessing extraordinary potency and breadth of spectrum, was too chemically unstable for clinical use (ref. 2). Imipenem was the result of a semi-synthetic analog program, is even more potent and is sufficiently stable for hospital use. A total synthesis was desired to produce imipenem commercially and to make analogs which could not be prepared by derivatization of the natural product. Totally synthetic analogs have been reported previously and this report details the synthesis of a new class of compounds. Imipenem showed yet another shortcoming. It was unstable to a kidney enzyme, renal dipeptidase I (or renal dehydropeptidase I, DHP-I) (ref. This report discusses more extensively on the 2-aryl class, as well as reporting the activities of those analogs having both functionalities.
The 1 -methy1carbapenems have proven to be the most interesting of the previously reported totally synthetic analogs. Biologically, these analogs have the interesting property of dramatically reducing DHP-I susceptibility while leaving the potency of the carbapenem nucleus unaffected. This series has been the focus of considerable synthetic effort and a stereoselective synthesis has been reported (ref . 11 ).
The critical ring-forming reaction in the thienamycin total synthesis is the insertion of the carbon bearing the diazo group into the NH bond of the azetidinone (ref. A. 1) NaOH, CH2OH/H20; 2) t-buty1dimethy1ch1orosilne/imidzo1e, DMF; 3) allyl glyoxylate, toluene, 4) thionyl chioride/pyridine, THF, -40 to -20 C; 5) triphenyl phosphine, DMF, r.t.; 6) HC1.
B. 2-pyridyl thiochioroformate/triethylamine, 0°C.
C. Grignard reagent, THF/ether, 00.
D. 1) , toluene or xylene; 2) tetra-n-butylammonium fluoride, HOAc, THF, r.t.; 3) tetrakistriphenyiphosphinepaliadium, potassium 2-ethythexanoate, triphenyiphosphine, EtOAc/CH2C12.
The previously reported methyl esters 4a (R=R'=H), 4b (R=CH3, R'H) and 4c (RH, R'CHq) were converted to the t-butyldimethylsilyl esters via the intermediate acid in order to facilitate s1ective hydrolysis at a later stage of the synthesis. Conversion of 4 to the phosphoranylidene free acids 5 was effected by sequential reaction with allyl glyoxylate, thionyl chloride and triphenyl phosphine without isolation of any of the intermediates. A deliberate hydrolysis step was included in the case of 4a and 4e. Conversion of 5 to the activated pyridylthio esters 6 was readily accomplished by reaction with 2-pyridyl thiochioroformate. The conversion of the starting methyl esters 4 to 6 was effected in overall 15-44% yields. 6 was the versatile synthetic intermediate desired in order to readily obtain a range of 2-arylcarbapenems. Reaction with an appropriate Grignard reagent afforded the corresponding arylketone 7. Yields ranged from 32-68%. Thermolysis of 7 readily afforded the protected carbapenem, which after desilylation (tetra-n-butylammonium fluoride/HOAc) and deesterification (ref. 15 ) gave the carbapenem 8. It is interesting to note that the 1 a-isomer is generated at lower temperatures than the other series investigated.
The antimicrobial activities of some representative analogs prepared by this sequence are given in Table I . Of primary interest is the effect of structural variation on DHP-I stability. It should be noted that the stability conferred by the 1 8-methyl and 2-aryl groups is neither additive nor synergistic, but indeed is diminished by their combined presence. Indeed, the la-methyl variant is most stable when aryl is 3-pyridyl. Generally, a methyl group at Cl diminishes potency regardless of stereochemistry, while this diminution is less pronounced in the case of the 1 8-methyl group. Finally, it has not been possible to restore meaningful anti-pseudomonal activity to the 2-aryl series despite the inclusion of basic groups in the 2-substituent. These results will be reported in detail elsewhere (ref. 16 ).
